SINTX Technologies Inc SINT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Prodways and SINTX Announce Joint Webinar Stay Ahead of the Curve: “Innovations in Ceramic Manufacturing: The Role of 3D Printing”
-
SINTX Announces Completion of $3.1 Million ATM Equity Public Offering
-
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
-
SINTX Provides Strategic Update: Significant Cost Reductions, Extended Cash Runway, and Exploration of Strategic Partnerships
-
SINTX Technologies Announces Appointment of Eric K. Olson as Chief Executive Officer
-
SINTX Technologies Awarded $2 Million Grant for Spinal Implant
Trading Information
- Previous Close Price
- $3.32
- Day Range
- $3.33–3.59
- 52-Week Range
- $2.75–180.00
- Bid/Ask
- $3.37 / $3.52
- Market Cap
- $2.59 Mil
- Volume/Avg
- 157,054 / 1.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.04
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 41
- Website
- https://www.sintx.com
Valuation
|
Metric
|
SINT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.29 |
Price/Sales | 0.04 |
Price/Cash Flow | — |
Price/Earnings
SINT
Financial Strength
|
Metric
|
SINT
|
|---|---|
Quick Ratio | 1.65 |
Current Ratio | 1.94 |
Interest Coverage | −1,448.00 |
Quick Ratio
SINT
Profitability
|
Metric
|
SINT
|
|---|---|
Return on Assets (Normalized) | −75.24% |
Return on Equity (Normalized) | −119.75% |
Return on Invested Capital (Normalized) | −91.10% |
Return on Assets
SINT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Jkbvckvdr | Xysgpc | $196.1 Bil | |||
| Stryker Corp
SYK
| Ctztwzvn | Dgwg | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Nwxhjryw | Nnntggh | $122.3 Bil | |||
| Medtronic PLC
MDT
| Fgtczhyf | Pfhnbxg | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Gdwgfyxg | Bzynbr | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Bbnc | Sjqs | $29.3 Bil | |||
| DexCom Inc
DXCM
| Qljbxglr | Yxk | $27.1 Bil | |||
| Steris PLC
STE
| Gbgjdlnws | Bltnskz | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Yklwsysvh | Khfxl | $21.9 Bil | |||
| Insulet Corp
PODD
| Yhwpsbdbps | Vyqcb | $16.5 Bil |
United States